systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
SLE_NOS
Extra metadata
List of similar endpoints to
Systemic lupus erythematosus, unspecified
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 561 | 478 | 83 |
| Unadjusted prevalence (%) | 0.22 | 0.33 | 0.07 |
| Mean age at first event (years) | 47.51 | 46.87 | 51.19 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.06 | 4.26 [2.32, 7.83] | 3.0e-6 | 43 |
| 15 years | 0.04 | 5.35 [3.12, 9.18] | 1.1e-9 | 39 |
| 5 years | 0.01 | 8.21 [3.94, 17.14] | 2.0e-8 | 19 |
| 1 year | - | - | - | - |
Index endpoint: SLE_NOS – Systemic lupus erythematosus, unspecified
GWS hits: 4
before Systemic lupus erythematosus, unspecified
after Systemic lupus erythematosus, unspecified
Loading survival analyses plot
Loading survival analyses table